BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 29788797)

  • 1. Characteristics of the Epithelial-Mesenchymal Transition in Primary and Paired Metastatic Canine Mammary Carcinomas.
    Raposo-Ferreira TMM; Brisson BK; Durham AC; Laufer-Amorim R; Kristiansen V; Puré E; Volk SW; Sorenmo K
    Vet Pathol; 2018 Sep; 55(5):622-633. PubMed ID: 29788797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Snail and slug play distinct roles during breast carcinoma progression.
    Côme C; Magnino F; Bibeau F; De Santa Barbara P; Becker KF; Theillet C; Savagner P
    Clin Cancer Res; 2006 Sep; 12(18):5395-402. PubMed ID: 17000672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.
    Cao YW; Wan GX; Sun JP; Cui XB; Hu JM; Liang WH; Zheng YQ; Li WQ; Li F
    Kaohsiung J Med Sci; 2015 Feb; 31(2):70-6. PubMed ID: 25645984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
    J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.
    Im KS; Kim JH; Kim NH; Yu CH; Hur TY; Sur JH
    J Comp Pathol; 2012; 147(2-3):121-8. PubMed ID: 22297072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
    Bozhkova DM; Poryazova-Markova EG
    Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of epithelial-mesenchymal transition in canine prostate cancer metastasis.
    Fonseca-Alves CE; Kobayashi PE; Rivera-Calderón LG; Laufer-Amorim R
    Res Vet Sci; 2015 Jun; 100():176-81. PubMed ID: 25796368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].
    He N; Wu GF; Zhao HY; Han HX
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):758-61. PubMed ID: 22336160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship Between E-Cadherin and its Transcriptional Repressors in Spontaneously Arising Canine Invasive Micropapillary Mammary Carcinoma.
    Gamba CO; Rodrigues MA; Gomes DA; Estrela-Lima A; Ferreira E; Cassali GD
    J Comp Pathol; 2015 Nov; 153(4):256-65. PubMed ID: 26385325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement.
    Brambs CE; Horn LC; Mende M; Höckel M; Eckey C; Hiller GGR; Höhn AK
    J Cancer Res Clin Oncol; 2022 May; 148(5):1183-1193. PubMed ID: 34495397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables.
    Matos AJ; Lopes C; Carvalheira J; Santos M; Rutteman GR; Gärtner F
    J Comp Pathol; 2006; 134(2-3):182-9. PubMed ID: 16545841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.
    Huang XY; Zhang C; Cai JB; Shi GM; Ke AW; Dong ZR; Zhang PF; Fan J; Peng BG; Zhou J
    PLoS One; 2014; 9(5):e96860. PubMed ID: 24816558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility.
    Stoyianni A; Goussia A; Pentheroudakis G; Siozopoulou V; Ioachim E; Krikelis D; Golfinopoulos V; Cervantes A; Bobos M; Fotsis T; Bellou S; Fountzilas G; Malamou-Mitsi V; Pavlidis N
    Anticancer Res; 2012 Apr; 32(4):1273-81. PubMed ID: 22493359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-localization of PTEN and E-cadherin in canine mammary hyperplasias and benign and malignant mammary tumors.
    Asproni P; Ressel L; Millanta F; Vannozzi I; Poli A
    Res Vet Sci; 2015 Dec; 103():113-8. PubMed ID: 26679805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
    Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
    BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma.
    Kurioka K; Wato M; Iseki T; Tanaka A; Morita S
    Med Mol Morphol; 2017 Jun; 50(2):68-75. PubMed ID: 27995335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
    Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H
    Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.
    Figueira AC; Gomes C; de Oliveira JT; Vilhena H; Carvalheira J; de Matos AJ; Pereira PD; Gärtner F
    BMC Vet Res; 2014 Nov; 10():270. PubMed ID: 25424750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localisation of cytokeratin and vimentin intermediate filament proteins in canine mammary tumours.
    Rabanal RM; Else RW
    Res Vet Sci; 1994 Mar; 56(2):225-33. PubMed ID: 7514803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model.
    Leonel C; Borin TF; de Carvalho Ferreira L; Moschetta MG; Bajgelman MC; Viloria-Petit AM; de Campos Zuccari DA
    J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):27-41. PubMed ID: 28078601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.